With a presence amongst the top 10 global veterinary pharmaceutical laboratories, Vetoquinol is first and foremost an independent, family-owned business. Deeply committed to its values, it has always enjoyed a close relationship with its vet clients.
Historically based in France, Vetoquinol currently develops, produces and distributes a range of medical and non-medical products and services in Europe, North America and Asia-Pacific. With a presence in 24 countries through its subsidiaries, its strong network of 100 distributor partners provides visibility for its products in more than 80 countries.
Historically based in France, Vetoquinol currently develops, produces and distributes a range of medical and non-medical products and services in Europe, North America and Asia-Pacific. With a presence in 24 countries through its subsidiaries, its strong network of 100 distributor partners provides visibility for its products in more than 80 countries.
Location: France
Employees: 1001-5000
Founded date: 1933
Investors 1
| Date | Name | Website |
| - | Azulis Cap... | azuliscapi... |
Mentions in press and media 5
| Date | Title | Description |
| 31.10.2025 | Health Biotech Strengthens Global Footprint at CPHI Frankfurt 2025 | New Delhi, Delhi, India Health Biotech Limited (Health Biotech), a research and development-driven pharmaceutical company from India, successfully concluded its participation at CPHI Frankfurt 2025. Considered one of the most respected glob... |
| 18.11.2021 | Vetoquinol : Felpreva®, Vetoquinol's New Three-Monthly Feline Parasiticide, Receives Marketing Authorisation from the European Commission | Felpreva® (tigolaner/emodepside/praziquantel) has been granted marketing authorisation by the European Commission The combination product is the first spot-on solution for cats approved in the EU to treat both internal and external parasite... |
| 13.10.2021 | Vetoquinol : UK achieves bronze accreditation with Investors in the Environment | Veterinary pharmaceuticals company, Vetoquinol UK, has achieved bronze accreditation with Investors in the Environment (iiE), the national environmental accreditation scheme. This meaningful accolade reflects Vetoquinol's commitment to more... |
| 13.09.2021 | Veterinary Parasiticide Felpreva® (tigolaner / emodepside / praziquantel) Receives Positive Opinion From European Committee for Medicinal Products for Veterinary Use (CVMP) | Vetoquinol (Paris: VETO) today announced that the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) has adopted a positive opinion recommending the granting of a marketing authorization of Felpreva® spot... |
| 01.06.2021 | VÉTOQUINOL SA Vetoquinol : Innovation - New light therapy supports skin recovery in pets | For faster skin recovery in dogs and cats, Vetoquinol has just introduced mid-May in the first country (Italy) a new device literally shining a light on dermatological pet struggles: Phovia. First wave of launches also includes DACH (Austri... |